PEAR1
Platelet endothelial aggregation receptor 1
Also known as: FLJ00193, JEDI, MEGF12, PEAR1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5VY43
- Gene
- PEAR1
- Ensembl
- ENSG00000187800
- Chromosome
- 1
- Canonical length
- 1037 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Cell Junctions,Centriolar satellite
OverviewNCBI Gene
PEAR1 is a platelet receptor that signals upon the formation of platelet-platelet contacts independent of platelet activation and secondary to platelet aggregation (Nanda et al., 2005 [PubMed 15851471]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
1037 residues, UniProt reviewed canonical sequence.
>Q5VY43|PEAR1
1 MSPPLCPLLL LAVGLRLAGT LNPSDPNTCS FWESFTTTTK ESHSRPFSLL PSEPCERPWE
61 GPHTCPQPTV VYRTVYRQVV KTDHRQRLQC CHGFYESRGF CVPLCAQECV HGRCVAPNQC
121 QCVPGWRGDD CSSECAPGMW GPQCDKPCSC GNNSSCDPKS GVCSCPSGLQ PPNCLQPCTP
181 GYYGPACQFR CQCHGAPCDP QTGACFCPAE RTGPSCDVSC SQGTSGFFCP STHSCQNGGV
241 FQTPQGSCSC PPGWMGTICS LPCPEGFHGP NCSQECRCHN GGLCDRFTGQ CRCAPGYTGD
301 RCREECPVGR FGQDCAETCD CAPDARCFPA NGACLCEHGF TGDRCTDRLC PDGFYGLSCQ
361 APCTCDREHS LSCHPMNGEC SCLPGWAGLH CNESCPQDTH GPGCQEHCLC LHGGVCQATS
421 GLCQCAPGYT GPHCASLCPP DTYGVNCSAR CSCENAIACS PIDGECVCKE GWQRGNCSVP
481 CPPGTWGFSC NASCQCAHEA VCSPQTGACT CTPGWHGAHC QLPCPKGQFG EGCASRCDCD
541 HSDGCDPVHG RCQCQAGWMG ARCHLSCPEG LWGVNCSNTC TCKNGGTCLP ENGNCVCAPG
601 FRGPSCQRSC QPGRYGKRCV PCKCANHSFC HPSNGTCYCL AGWTGPDCSQ PCPPGHWGEN
661 CAQTCQCHHG GTCHPQDGSC ICPLGWTGHH CLEGCPLGTF GANCSQPCQC GPGEKCHPET
721 GACVCPPGHS GAPCRIGIQE PFTVMPTTPV AYNSLGAVIG IAVLGSLVVA LVALFIGYRH
781 WQKGKEHHHL AVAYSSGRLD GSEYVMPDVP PSYSHYYSNP SYHTLSQCSP NPPPPNKVPG
841 PLFASLQNPE RPGGAQGHDN HTTLPADWKH RREPPPGPLD RGSSRLDRSY SYSYSNGPGP
901 FYNKGLISEE ELGASVASLS SENPYATIRD LPSLPGGPRE SSYMEMKGPP SGSPPRQPPQ
961 FWDSQRRRQP QPQRDSGTYE QPSPLIHDRD SVGSQPPLPP GLPPGHYDSP KNSHIPGHYD
1021 LPPVRHPPSP PLRRQDRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PEAR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 17 nTPM
- adipose tissue: 16 nTPM
- breast: 11 nTPM
- placenta: 11 nTPM
- cervix: 10 nTPM
- lung: 9.9 nTPM
Single-cell type
- platelets: 316 nCPM
- pericytes: 68 nCPM
- lymphatic endothelial cells: 61 nCPM
- leydig cells: 59 nCPM
- peritubular myoid cells: 45 nCPM
- vascular smooth muscle cells: 43 nCPM
Immune cell
- total PBMC: 0.4 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 8.3 nTPM
- basal ganglia: 7.7 nTPM
- thalamus: 7.7 nTPM
- amygdala: 6.6 nTPM
- midbrain: 6.3 nTPM
- pons: 6.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.89
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.71
- DepMap mean gene effect
- -0.27
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- phosphatidylinositol 3-kinase/protein kinase B signal transduction
- platelet aggregation
- positive regulation of platelet activation
- recognition of apoptotic cell
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PEAR1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PEAR1 as an antibody target. Whether an autoantibody or antibody against PEAR1 could matter depends on whether native PEAR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PEAR1 is annotated at the cell surface, where native PEAR1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PEAR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...